Acute effects of glaucoma medications and benzalkonium chloride on pre-adipocyte proliferation and adipocyte cytotoxicity in vitro

Current Eye Research

Volumn 38, Issue 1, 2013, Pages 70-74

  Seibold, Leonard K ^a   Ammar, David A ^a   Kahook, Malik Y ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Adipocyte; Benzalkonium Chloride; Eyelids; Glaucoma; Prostaglandins

Indexed keywords

BENZALKONIUM CHLORIDE; BIMATOPROST; LATANOPROST; TAFLUPROST; TIMOLOL MALEATE; TRAVOPROST;

ADIPOCYTE; ARTICLE; CELL PROLIFERATION; CYTOTOXICITY; DRUG EFFECT; FLUORESCENCE ANALYSIS; GLAUCOMA; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; PRE ADIPOCYTE; PRIORITY JOURNAL;

ADIPOCYTES; ANTIHYPERTENSIVE AGENTS; BENZALKONIUM COMPOUNDS; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DRUG THERAPY, COMBINATION; GLAUCOMA; HUMANS; OPHTHALMIC SOLUTIONS; PRESERVATIVES, PHARMACEUTICAL;

EID: 84872046341     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2012.733055     Document Type: Article

References (14)

1. Yam JC, Yuen NS, Chan CW. Bilateral deepening of upper lid sulcus from topical bimatoprost therapy. J Ocul Pharmacol Ther 2009;25:471-472
2. Peplinski LS, Albiani Smith K. Deepening of lid sulcus from topical bimatoprost therapy. Optom Vis Sci 2004;81: 574-577
3. Filippopoulos T, Paula JS, Torun N, Hatton MP, Pasquale LR, Grosskreutz CL. Periorbital changes associated with topical bimatoprost. Ophthal Plast Reconstr Surg 2008;24:302-307
4. Park J, Cho HK, Moon JI. Changes to upper eyelid orbital fat from use of topical bimatoprost, travoprost, and latanoprost. Jpn J Ophthalmol 2011;55:22-27
5. Pasquale LR. Prostaglandin-Associated Periorbitopathy (A postmarketing surveillance observation). Glaucoma Today 2011:51-2,8
6. Casimir DA, Miller CW, Ntambi JM. Preadipocyte differentiation blocked by prostaglandin stimulation of prostanoid FP2 receptor in murine 3T3-L1 cells. Differentiation 1996;60:203-210
7. Alm A, Grierson I, Shields MB. Side effects associated with prostaglandin analog therapy. Surv Ophthalmol 2008;53 SUPPL1:S93-105
8. Tappeiner C, Perren B, Iliev ME, Frueh BE, Goldblum D. [Orbital fat atrophy in glaucoma patients treated with topical bimatoprost-can bimatoprost cause enophthalmos?]. Klin Monbl Augenheilkd 2008;225:443-445
9. Romano MR, Lograno MD. Evidence for the involvement of cannabinoid CB1 receptors in the bimatoprost-induced contractions on the human isolated ciliary muscle. Invest Ophthalmol Vis Sci 2007;48:3677-3682
10. Altieri M, Ferrari E. Do prostaglandin analogs affect eyelid position and motility? J Ocul Pharmacol Ther 2011;27:511-517
11. Ammar DA, Noecker RJ, Kahook MY. Effects of benzalkonium chloride- And polyquad-preserved combination glaucoma medications on cultured human ocular surface cells. Adv Ther 2011;28:501-510
12. Ammar DA, Kahook MY. Effects of benzalkonium chloride-or polyquad-preserved fixed combination glaucoma medications on human trabecular meshwork cells. Mol Vis 2011;17:1806-1813
13. Kahook MY, Ammar DA. In vitro toxicity of topical ocular prostaglandin analogs and preservatives on corneal epithelial cells. J Ocul Pharmacol Ther 2010;26:259-263
14. Choi HY, Lee JE, Lee JW, Park HJ, Lee JE, Jung JH. In vitro study of antiadipogenic profile of latanoprost, travoprost, bimatoprost, and tafluprost in human orbital preadiopocytes. J Ocul Pharmacol Ther 2012;28:146-152